Chair: H.-F. Langer (Tübingen), S. Massberg (München)
| (V936) | Development of novel antiplatelet drugs |
| K. Peter (Central Melbourne, AU) | |
| (V937) | Platelet function in Diabetes |
| I. Fleming (Frankfurt am Main) | |
| (V938) | Revacept (dimeric GPVI-Fc) a lesion-specific inhibitor for plaque-mediated platelet aggregation without affecting general haemostasis |
| G. Münch (Martinsried) | |
| (V939) | Molecular Imaging of atherosclerotic Plaques and vascular lesions |
| B. Bigalke (Tübingen) | |
| (V940) | Molecular imaging of inflammation making use of platelet markers |
| C. von zur Mühlen (Freiburg im Breisgau) |